Plant Response Biotech
Latest round
- Series B
Last raised
- Dec 2018
Total raised
- $13M
Investors
- 7
About Plant Response Biotech
Plant Response Biotech, Inc.Plant Response Biotech, Inc.L. and Koch Biological Solutions, LLC, aiming to integrate their capabilities and assets. The company is headquartered in Raleigh, US. Tom Snipes serves as the CEO. In December 2021, the Mosaic Company acquired Plant Response Biotech, Inc. for an undisclosed amount, further enhancing its presence in soil-health products.Plant Response Biotech, Inc. focuses on developing advanced biological solutions and products that improve soil health and crop yields. Their offerings are designed to optimize plant nutrition and enhance the interactions within the soil microbiome.Plant Response Biotech, Inc. generates revenue through the sale of its advanced agricultural products and solutions, which include tailored offerings for both large agribusinesses and smallholder farmers. Plant Response Biotech, Inc. aims to enter new markets across North America and Europe by 2024.
Who invested in Plant Response Biotech
7 investors across 2 rounds
See all investors in Plant Response Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Plant Response Biotech
Who invested in Plant Response Biotech?
Plant Response Biotech has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Plant Response Biotech raised?
Plant Response Biotech has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Plant Response Biotech last raise money?
Plant Response Biotech's most recent round on record is a Series B, in Dec 2018.
What does Plant Response Biotech do?
Plant Response Biotech is a biotechnology company.
Where is Plant Response Biotech headquartered?
Plant Response Biotech is headquartered in Raleigh, US.
Which VCs invest in companies like Plant Response Biotech?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Plant Response Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Plant Response Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.